PPARG and metabolic dysfunction-associated steatotic liver disease: PPARγ was another transcription factor, which was a part of our validated DEGs and showed a good correlation with NAS, steatosis and inflammation degree of the patients and the role of PPARγ in NAFLD is also well established [19].